INDP Indaptus Year-over-year net earnings per share growth for the last 12 months
The quarterly EPS percentage change reflects the financial standing of Indaptus Therapeutics (INDP), where 100.00 represents the current level of the metric. The company is utilizing accumulated reserves for early-stage testing in the absence of revenue. Growth is driven by the development of the decOyp platform for tumor combat and M&A potential. The strategy is based on creating bacterial immunotherapies to activate the body's defenses within cancerous tissues.
Summary analytical data breakdowns for Indaptus Corp (INDP)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital Indaptus Therapeutics|INDP - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Indaptus Therapeutics|INDP - Company Aggregate Debt|Debts to Book Capitalization Indaptus|INDP - Company Long-Term Indebtedness|Company Short-Term Debts Indaptus Therapeutics|Quick Liquidity indaptusrx.com
- earnings and market multiples details:
INDP - Profit After Tax|Future Profit Indaptus Therapeutics|INDP - Market Price to Net Income Ratio|Projected Price to Earnings Indaptus|INDP - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Indaptus|INDP - Operating income before deduction of amortization|Net earnings per share for the last 12 months Indaptus Therapeutics|INDP - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months indaptusrx.com|INDP - Net earnings per one share growth for the current year|Earnings growth forecast for next year Indaptus Therapeutics
Summary company analysis:Indaptus Therapeutics, Inc. - INDP
For Indaptus Therapeutics (INDP), which focuses on early-stage clinical trials and cell line partnerships, profit is a derivative of capital burn efficiency. The history of quarterly earnings per share changes reflects the market reaction to 10-Q reports, allowing for the separation of fundamental business resilience from speculative price volatility driven by investors' emotional perception of drug development timelines.
Key competitors
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Celldex Corp CLDX|Aurinia Pharmaceuticals (AUPH) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months BCRX|VERA (Vera Therapeutics) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months DNTH (Dianthus Therapeutics Inc)|Quarterly EPS earnings growth PHVS|Quarterly EPS earnings growth AbCellera Bio (ABCL)|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio, Inc. TRML|PGEN (precigen.com) - Year-over-year net earnings per share trend for the last twelve months|PHAR: Year-over-year net earnings per share growth for the last 12 months|Nektar Therapeutics Inc - Year-over-year earnings per share growth rate for the last twelve months|UPB (Upstream Bio Corp) - Year-over-year net earnings per share growth for the last 12 months|Zenas Corp (ZBIO) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Immunome, Inc.|gossamerbio.com (GOSS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months KALV (KalVista Pharmaceuticals, Inc.)|SEPN (Septerna, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Pieris Pharmaceuticals Inc - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months SVRA (Savara Pharma)|Rigel Pharmaceuticals - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months ANAB (anaptysbio.com)|ATXS: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months enGene Holdings Inc (ENGN)|Year-over-year earnings per share growth for the last twelve months RAPT Therapeutics|JBIO: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACRS|Quarterly EPS earnings growth kyvernatx.com (KYTX)|Year-over-year earnings per share growth for the last twelve months Tiziana Life Sciences Ltd TLSA|CABA (Cabaletta Bio Inc.) - Year-over-year net earnings per share trend for the last twelve months|Ventyx Bio - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Theratechnologies, Inc|AVTX (Avalo Therapeutics, Inc) - Year-over-year net earnings per share growth for the last 12 months|eledon.com (ELDN) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months AGEN|CLYM (Climb Bio Inc.) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth ZURA|Year-over-year net earnings per share change for the last twelve months aTyr Pharmaceuticals|Quarterly EPS earnings growth ADAG (Adagene Inc.)|IMA - Year-over-year net earnings per share growth for the last 12 months|STTK - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Equillium, Inc. EQ|CNTB: Quarterly EPS earnings growth|IMUX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Atara Biotherapeutics, Inc.|Year-over-year earnings per share growth for the last 12 months IFRX (InflaRx GmbH)|Quarterly EPS earnings growth XFOR|adicetbio.com - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Celularity CELU|INMB (INmune Bio Corporation) - Year-over-year net earnings per share trend for the last twelve months|BRNS - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months KZR|SABS: Quarterly EPS earnings growth|Akari Therapeutics PLC - Year-over-year earnings per one share growth for the last 12 months|ENLV (Enlivex Therapeutics Ltd) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Q32 Bio Corp|Year-over-year earnings per share growth for the last twelve months GeoVax Labs, Inc. (GOVX)|EDSA (edesabiotech.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months iBio IBIO|CARM - Year-over-year net earnings per share growth for the last 12 months|XTL Biopharmaceuticals, Ltd. - Quarterly EPS earnings growth|BOLT - Quarterly EPS earnings growth|HCWB (hcwbiologics.com) - Year-over-year net earnings per share growth for the last 12 months|Aptevo Therapeutics Inc. - Year-over-year earnings per one share growth for the last 12 months|AIM (AIM ImmunoTech Inc.) - Quarterly EPS earnings growth|Aditxt Corp (ADTX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months GRI Bio Corp (GRI)|Year-over-year net earnings per share growth for the last 12 months XORTX Corp XRTX|Year-over-year earnings per share growth for the last twelve months Vyome Holdings Inc HIND|REVB - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI - Quarterly EPS earnings growth|affimed.com (AFMD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ALLK|HOOK (HOOKIPA Pharma, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months IGM Bio IGMS|Quarterly EPS earnings growth ITOS|Year-over-year net earnings per share change for the last twelve months Ocean Biomedical Inc|Year-over-year earnings per share growth for the last twelve months TC BioPharm (Holdings) PLC TCBP|THRD: Year-over-year earnings per share growth for the last 12 months
